Abstract:Background Tumor mutational burden (TMB) is a potential genomic biomarker that can help identify patients who will benefit from immunotherapy across a variety of cancers. However, TMB detected through whole exome sequencing lacks clinical penetration in low-resource settings due to the high cost, operational complexity, and lengthy time for test. Therefore, a scalable and time-efficient approach for the identification of TMB status with low cost is desirable for patients. Methods We included whole slide images (WSIs) of 3228 diagnostic slides from the Cancer Genome Atlas and 531 WSIs from the Clinical Proteomic Tumor Analysis Consortium for the development and verification of a pan-cancer TMB prediction model (PC-TMB). We proposed a multiscale weakly-supervised deep learning framework for predicting TMB of seven types of tumors based only on routinely used hematoxylin-eosin (H&E)-stained WSIs. Results PC-TMB achieved a mean area under curve (AUC) of 0.818 (0.804-0.831) in the cross-validation cohort, which was superior to the best single-scale model. In comparison with the state-of-the-art TMB prediction model from previous publications, our multiscale model achieved better performance over previously reported models. In addition, the improvements of PC-TMB over the single-tumor models were also confirmed by the ablation tests on ×10 magnification. The PC-TMB algorithm also exhibited good generalization on external validation cohort with AUC of 0.732 (0.683-0.761). PC-TMB possessed a comparable survival-risk stratification performance to the TMB measured by whole exome sequencing, but with low cost and being time-efficient for providing a prognostic biomarker of multiple solid tumors. Moreover, spatial heterogeneity of TMB within tumors was also identified through our PC-TMB, which might enable image-based screening for molecular biomarkers with spatial variation and potential exploring for genotype-spatial heterogeneity relationships.

Topical hidden genome: discovering latent cancer mutational topics using a Bayesian multilevel context-learning approach

Using the "Hidden" Genome to Improve Classification of Cancer Types

Identifying somatic fingerprints of cancers defined by germline and environmental risk factors

Is Seeing Believing? A Practitioner's Perspective on High-Dimensional Statistical Inference in Cancer Genomics Studies

Correlated Mixed Membership Modeling of Somatic Mutations

Multifactorial Deep Learning Reveals Pan-Cancer Genomic Tumor Clusters with Distinct Immunogenomic Landscape and Response to Immunotherapy.

Hierarchical Bayesian analysis of somatic mutation data in cancer

Gene Expression based Survival Prediction for Cancer Patients: A Topic Modeling Approach

Cancer classification and pathway discovery using non-negative matrix factorization

Bayesian modeling of mutual exclusivity in cancer mutations

A Pan-Cancer and Polygenic Bayesian Hierarchical Model for the Effect of Somatic Mutations on Survival

Inference of mutability landscapes of tumors from single cell sequencing data

A clustering approach to integrative analyses of multiomic cancer data

Understanding Breast Cancer Survival: Using Causality and Language Models on Multi-omics Data

Deep learning-based approach to reveal tumor mutational burden status from whole slide images across multiple cancer types

Bayesian multi-domain learning for cancer subtype discovery from next-generation sequencing count data

Pan-cancer Computational Histopathology Reveals Tumor Mutational Burden Status Through Weakly-Supervised Deep Learning.

Survival-supervised latent Dirichlet allocation models for genomic analysis of time-to-event outcomes

Integrating Multi-Modal Cancer Data Using Deep Latent Variable Path Modelling

An integrative analysis of cancer gene expression studies using Bayesian latent factor modeling

NetNorM: Capturing cancer-relevant information in somatic exome mutation data with gene networks for cancer stratification and prognosis